DEXA Scans: Bone Health and Androgen Deprivation Therapy (ADT) for Prostate Cancer

[madman]

To view this content we will need your consent to set third party cookies.
For more detailed information, see our cookies page.

Accept third party cookies

In this 12-minute presentation, Mark A. Moyad, MD, MPH, interviews Celestia S. Higano, MD, FACP, about the importance of dual-energy X-ray absorptiometry (DEXA) screening to preserve bone health in men initiating androgen deprivation therapy (ADT).